Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1
Clinical trial NCT05553808 · COMPLETED
Trial details
- NCT number
- NCT05553808
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2021-09-23
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.